Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Caliper Technologies Corp., Zymark Corp. deal

CALP will acquire laboratory automation company Zymark for about $57 million in cash and 3.15

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE